Clomid is a brand name for the medication clomifene (clomiphene citrate). It belongs to the women’s health category and is manufactured in pill form. In Hong Kong, Clomid is a prescription-only product regulated by the Department of Health’s Pharmacy and Poisons Board. It is most commonly prescribed to stimulate ovulation in women who have difficulty becoming pregnant due to anovulation or irregular ovulation.
Available capsule strengths are 25 mg, 50 mg, and 100 mg.
Clomifene is a selective estrogen receptor modulator (SERM). It binds to estrogen receptors in the hypothalamus, blocking the normal feedback inhibition normally provided by circulating estrogen. This blockage leads to:
The drug’s onset of action typically occurs within 5-7 days of the first dose, with the peak ovulatory response seen around day 10-14 of a typical 5-day treatment cycle. Because clomifene’s half-life ranges from 5 to 7 days, steady-state concentrations are achieved after a few dosing cycles.
Clomid is approved in Hong Kong for:
These indications are based on extensive clinical experience and regulatory review confirming clomifene’s effectiveness in producing mature oocytes and improving pregnancy rates in the indicated populations.
Disclaimer: Off-label use requires medical supervision and individualized risk assessment.
Ideal candidates are women of reproductive age with documented anovulation who are otherwise healthy and have no contraindicating medical conditions.
If any of the above conditions are present, a healthcare professional must evaluate the risk-benefit profile before initiating therapy.
These effects usually lessen after the first treatment cycle.
Because interaction data for clomifene are not exhaustive, patients should disclose all prescription drugs, over-the-counter products, supplements, and herbal preparations before starting Clomid.
Only the strengths listed (25 mg, 50 mg, 100 mg) should be used; tablets should not be split or crushed unless specifically instructed.
This article provides educational information about Clomid and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes. Clomid is one of the first-line treatments for ovulation induction in women with PCOS who are anovulatory. The dose may be adjusted based on ultrasound monitoring of follicular response.
Ovulation typically occurs 5-10 days after the last tablet. Couples are advised to have intercourse during the fertile window, usually spanning the day of ovulation and the two days before.
Travel does not affect clomifene’s efficacy, but keep the medication in its original labeled container, carry a copy of the prescription, and be aware of Hong Kong’s customs regulations regarding prescription drugs.
Clomid can alter cycle length; some women experience a slightly shorter luteal phase, while others notice a delay in the next period, especially if ovulation does not occur.
Off-label, clomifene has been studied for raising testosterone in men with hypogonadism, but this use is not approved in Hong Kong and should only be considered under specialist care.
Look for rapid abdominal swelling, severe pelvic pain, shortness of breath, decreased urination, and sudden weight gain (>2 kg in 24 hours). Seek medical attention immediately if these occur.
Any concurrent fertility drugs should be reviewed by your physician. In many protocols, Clomid replaces-or is sequenced after-other oral agents, but abrupt discontinuation without medical advice is not recommended.
Clomid is a SERM, while letrozole is an aromatase inhibitor. Letrozole has a shorter half-life and may carry a lower risk of multiple pregnancies, but both are effective; the choice depends on individual response and physician preference.
Clomid does not prevent pregnancy; it is intended to facilitate conception. If pregnancy is confirmed, the medication should be discontinued promptly.
Clomifene is classified as a Category X drug in many jurisdictions, meaning it is contraindicated in pregnancy due to potential teratogenic effects. If pregnancy occurs, discontinue the drug and inform your healthcare provider.
